FOLH1 and neoplasm: The IRDye700DX confers to the molecule a bimodal feature for aiding surgeons in delineating positive tumour margins during surgery and triggering after surgery tPDT cytotoxicity on possible not resected tumour cells, while PSMA-617 confers superior specificity compared to the previous reported molecules.